We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




FDA Approves MR-Conditional Pacemaker

By HospiMedica International staff writers
Posted on 28 Aug 2017
A new, small, MR-conditional cardiac resynchronization therapy pacemaker is now commercially available following US FDA approval.

The device has a volume of only 15 cc and can last nearly 10 years, reducing the number of device replacements needed by heart failure patients.

The Edora HF-T QP device was developed by BIOTRONIK (Lake Oswego, OR), and is the smallest Magnetic Resonance (MR) conditional QuadriPolar (QP), Cardiac Resynchronization Therapy Pacemaker (CRT-P) available in the US.

The device features MRI AutoDetect technology, and Closed Loop Stimulation (CLS). More...
The BIOTRONIK Home Monitoring includes Heart Failure Monitor Online functionality that provides a thoracic impedance data and other long-term heart failure statistics. Daily updates enable clinicians to monitor and evaluate patients’ heart failure status throughout the day, and view statistical trends. BIOTRONIK Home is also the only cardiac-device remote monitoring system available with clinically proven improved health outcomes for heart failure patients.

Chicago-based cardiac electrophysiologist, Dr. Roderick Tung, said, “Patient care is a constant journey. It doesn’t end when the patient leaves my office or recovers from a procedure. As healthcare providers, we must think beyond today and help ensure patients are appropriately cared for throughout their lifetime. MR conditional CRT-Ps that can be programmed to automatically switch to MRI mode when they enter the MRI environment are another significant step in delivering the best possible care throughout the patient journey. This technology eliminates an office visit for patients and decreases administrative burden for providers. The impact is significant, especially in institutions that perform cardiac MRI for advanced ventricular care."


Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Multi-Chamber Washer-Disinfector
WD 390
Surgical Dressing
ALLEVYN Ag+ SURGICAL
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Graphical Abstract (Aoibhin M. Sheedy et al., A replenishable peritoneal implant for localized delivery and peritoneal fluid sampling in ovarian cancer, Device (2026). DOI: 10.1016/j.device.2026.101050)

New Implant Provides Sustained Localized Therapy for Ovarian Cancer

Ovarian cancer is often diagnosed at advanced stages because symptoms such as bloating, pain, and pelvic pressure are nonspecific. Standard care relies on surgery and systemic therapy, yet tools for targeted... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.